|
UBA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.879800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.059410E-03 |
| Normal-vs-Stage2 |
5.009800E-01 |
| Normal-vs-Stage3 |
1.575830E-01 |
| Normal-vs-Stage4 |
1.024800E-01 |
| Stage1-vs-Stage2 |
2.969400E-01 |
| Stage1-vs-Stage3 |
2.027900E-02 |
| Stage1-vs-Stage4 |
8.505000E-03 |
| Stage2-vs-Stage3 |
1.065790E-01 |
| Stage2-vs-Stage4 |
6.808100E-02 |
| Stage3-vs-Stage4 |
8.407000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.330300E-02 |
| Normal-vs-AfricanAmerican |
2.390000E-01 |
| Normal-vs-Asian |
7.488600E-01 |
| Caucasian-vs-AfricanAmerican |
7.957800E-01 |
| Caucasian-vs-Asian |
8.621000E-01 |
| AfricanAmerican-vs-Asian |
8.979200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.160100E-03 |
| Normal-vs-Female |
2.178600E-01 |
| Male-vs-Female |
9.204700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.605800E-01 |
| Normal-vs-Extreme_Weight |
5.657900E-02 |
| Normal-vs-Obese |
9.460400E-01 |
| Normal-vs-Extreme_Obese |
7.927800E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.937000E-01 |
| Normal_Weight-vs-Obese |
5.068400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.435400E-01 |
| Extreme_Weight-vs-Obese |
1.542440E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.952400E-01 |
| Obese-vs-Extreme_Obese |
2.165200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.346240E-01 |
| Normal-vs-Age(41-60Yrs) |
2.789000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.909700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.221670E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.037800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.262000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.172090E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.642190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.485500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.487400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.616860E-03 |
| Normal-VS-Type2 PRCC |
4.321600E-01 |
| Normal-VS-KIRP CIMP |
2.087800E-02 |
| Normal-VS-Unclassified PRCC |
1.960600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.603200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.200900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.578600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.379600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.944000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.758400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.867600E-01 |
| Normal-vs-N1 |
1.014420E-02 |
| Normal-vs-N2 |
5.546000E-01 |
| N0-vs-N1 |
1.022190E-02 |
| N0-vs-N2 |
6.739000E-01 |
| N1-vs-N2 |
3.567800E-01 |
|
|
